Search Within

Heiko Schoder

  1. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (75)
  2. Meeting Abstract (67)
  3. Research Letter (4)
Groups
  1. Center for Hematologic Malignancies (146)
  2. Molecular Imaging and Therapy Service (146)
  3. Radiology, Department of (146)
  4. Department of Medicine (141)
  5. Hematologic Malignancies, Division of (135)
  6. Lymphoma (128)

More Groups

People
  1. Andrew Zelenetz (66)
  2. Alison Moskowitz (59)
  3. David Straus (56)
  4. Ariela Noy (55)
  5. Maria Palomba (53)
  6. Paul Hamlin (51)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2023 (17)
  4. 2022 (7)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. Blood (49)
  2. Journal of Clinical Oncology (17)
  3. Hematological Oncology (11)
  4. International Journal of Radiation Oncology, Biology, Physics (7)
  5. Blood Advances (6)
  6. Leukemia and Lymphoma (5)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (17)
  3. Wiley Blackwell (14)
  4. Elsevier Inc. (8)
  5. Nature Publishing Group (6)
  6. Springer (6)

More Publishers

Results (146)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Majority of transformed lymphomas have high SUVs on PET scanning similar to diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Weissler, M.; Noy, A.; Schoder, H.; Gonen, M.; Yeung, H.
    Blood (2006)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    Meeting Abstract

    Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • FOG-PET for staging of rhabdomyosarcoma
    Meeting Abstract

    Klem, M. L.; Grewal, R.; Wexler, L. H.; Schoder, H.; Meyers, P. A.; Wolden, S. L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma
    Journal Article

    Schoder, H.; Noy, A.; Gonen, M.; Weng, L.; Green, D.; Erdi, Y. E.; Larson, S. M.; Yeung, H. W. D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Head to head comparison of Gallium-67 imaging and FDG PET in lymphoma patients
    Meeting Abstract

    Schoder, H.; Noy, A.; Gonen, M.; Young, K. S.; Larson, S. M.; Yeung, H. W.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Diagnostic and prognostic value of [18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma
    Journal Article

    Wong, R. J.; Lin, D. T.; Schòˆder, H.; Patel, S. G.; Gonen, M.; Wolden, S.; Pfister, D. G.; Shah, J. P.; Larson, S. M.; Kraus, D. H.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save